Jasper Therapeutics (JSPR) News Today

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

$21.59

-1.62 (-6.98%)

(As of 04/19/2024 ET)

Source

Source	Headline
	Analyzing Finch Therapeutics Group (NASDAQ:FNCH) and Jasper Therapeutics (NASDAQ:JSPR) americanbankingnews.com - April 13 at 2:28 AM
	Jasper Therapeutics (NASDAQ:JSPR) Research Coverage Started at Evercore ISI marketbeat.com - April 3 at 8:18 AM
	Jasper Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference globenewswire.com - April 2 at 4:30 PM
	Jasper Therapeutics, Inc. (NASDAQ:JSPR) Receives Average Recommendation of "Buy" from Analysts marketbeat.com - April 1 at 6:14 AM
	RBC starts Jasper Therapeutics at outperform, cites market opportunity msn.com - March 28 at 8:09 PM
	Jasper Therapeutics (NASDAQ:JSPR) Receives New Coverage from Analysts at Royal Bank of Canada marketbeat.com - March 28 at 8:28 AM
	Jasper Therapeutics to Participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference globenewswire.com - March 21 at 4:30 PM
	Buy Rating Affirmed for Jasper Therapeutics as Briquilimab Shows Market Potential in Chronic Urticaria Treatment markets.businessinsider.com - March 20 at 5:07 PM
	Jasper Therapeutics, Inc.'s (NASDAQ:JSPR) largest shareholders are retail investors with 42% ownership, institutions own 26% finance.yahoo.com - March 20 at 5:07 PM
	Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a SPOTLIGHT Clinical Study of Briquilimab in Chronic Inducible Urticaria globenewswire.com - March 19 at 8:00 AM
	Jasper Therapeutics (NASDAQ:JSPR) Earns Outperform Rating from Analysts at TD Cowen marketbeat.com - March 18 at 8:28 AM
	JSPR Jul 2024 40.000 call finance.yahoo.com - March 16 at 2:35 PM
	Jasper Therapeutics, Inc.: New Positive Data Presented on Briquilimab Conditioning in Patients with Fanconi Anemia finanznachrichten.de - March 15 at 9:44 AM
	New Positive Data Presented on Briquilimab Conditioning in Patients with Fanconi Anemia globenewswire.com - March 15 at 8:00 AM
	Entrada Therapeutics GAAP EPS of -$0.29 beats by $0.81, revenue of $41.85M msn.com - March 14 at 8:03 AM
	Jeetinder Singh Mahal Sells 900 Shares of Jasper Therapeutics, Inc. (NASDAQ:JSPR) Stock insidertrades.com - March 13 at 7:20 AM
	Insider Selling: Jasper Therapeutics, Inc. (NASDAQ:JSPR) COO Sells 900 Shares of Stock marketbeat.com - March 12 at 10:43 PM
	JSPR Oct 2024 30.000 call finance.yahoo.com - March 11 at 10:10 AM
	JSPR Oct 2024 17.500 call finance.yahoo.com - March 10 at 5:48 PM
	JSPR Apr 2024 35.000 call finance.yahoo.com - March 10 at 5:48 PM
	Jasper Therapeutics, Inc. (NASDAQ:JSPR) Receives Consensus Recommendation of "Buy" from Analysts marketbeat.com - March 7 at 9:45 AM
	Oppenheimer Reiterates "Outperform" Rating for Jasper Therapeutics (NASDAQ:JSPR) marketbeat.com - March 7 at 8:43 AM
	Jasper Therapeutics, Inc. to Post Q1 2024 Earnings of ($1.19) Per Share, Capital One Financial Forecasts (NASDAQ:JSPR) marketbeat.com - March 7 at 6:40 AM
	JSPR Mar 2024 22.500 put finance.yahoo.com - March 6 at 11:37 PM
	JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q4 2023 investorplace.com - March 6 at 2:00 PM
	William Blair Weighs in on Jasper Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:JSPR) marketbeat.com - March 6 at 7:32 AM
	Buy Rating Affirmed: Jasper Therapeutics’ Progress and Potential in Addressing Unmet Needs in Chronic Urticaria Treatment markets.businessinsider.com - March 4 at 10:37 PM
	Jasper Therapeutics, Inc.: Jasper Therapeutics Reports Fiscal 2023 Financial Results and Recent Corporate Developments finanznachrichten.de - March 4 at 12:35 PM
	Jasper Therapeutics Reports Fiscal 2023 Financial Results and Recent Corporate Developments globenewswire.com - March 4 at 7:30 AM
	JSPR Mar 2024 15.000 put finance.yahoo.com - March 3 at 8:07 PM
	Oppenheimer Reaffirms Their Buy Rating on Jasper Therapeutics (JSPR) markets.businessinsider.com - February 27 at 4:27 PM
	Buy Rating on Jasper Therapeutics Highlighting Briquilimab’s Potential in Chronic Urticaria Treatment markets.businessinsider.com - February 27 at 9:21 AM
	Jasper Therapeutics to Present at the 43rd Annual TD Cowen Healthcare Conference globenewswire.com - February 26 at 4:30 PM
	Jasper Therapeutics Presents Data from Preclinical Briquilimab Studies at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting globenewswire.com - February 23 at 8:00 AM
	Capital One Financial Weighs in on Jasper Therapeutics, Inc.'s FY2023 Earnings (NASDAQ:JSPR) marketbeat.com - February 23 at 6:34 AM
	JSPR Mar 2024 20.000 call finance.yahoo.com - February 23 at 1:02 AM
	JSPR Jul 2024 22.500 call finance.yahoo.com - February 23 at 1:01 AM
	Buy Rating for Jasper Therapeutics: Promising Developments in CSU Treatment Pipeline and Anticipated Clinical Milestones markets.businessinsider.com - February 22 at 10:00 AM
	JSPR Apr 2024 2.500 call ca.finance.yahoo.com - February 19 at 3:28 PM
	JSPR Jul 2024 2.500 call ca.finance.yahoo.com - February 19 at 3:28 PM
	Here's What Could Help Jasper Therapeutics, Inc. (JSPR) Maintain Its Recent Price Strength msn.com - February 19 at 3:28 PM
	JSPR Mar 2024 15.000 call finance.yahoo.com - February 17 at 2:30 AM
	JSPR Mar 2024 12.500 put finance.yahoo.com - February 17 at 2:30 AM
	Velan Capital Investment Manag Purchases 350,000 Shares of Jasper Therapeutics, Inc. (NASDAQ:JSPR) Stock marketbeat.com - February 9 at 9:15 PM
	Jasper Therapeutics Announces Offering Pricing Details msn.com - February 7 at 12:37 PM
	Jasper Therapeutics Launches $50M Share Offering msn.com - February 7 at 12:37 PM
	Jasper Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Conference finance.yahoo.com - February 7 at 12:37 PM
	Jasper Therapeutics Shares Rise 20% After Offering Prices marketwatch.com - February 6 at 7:48 PM
	Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock finance.yahoo.com - February 6 at 9:47 AM
	Jasper Therapeutics Announces Preclinical Data Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting finance.yahoo.com - February 5 at 8:29 AM

Get Jasper Therapeutics News Delivered to You Automatically

Secret Bull Market Starts in This Unusual Sector (Ad)

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

JSPR Media Mentions By Week

JSPR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

JSPR
News Sentiment
▼
0.00

0.52
▲
Average
Medical
News Sentiment

JSPR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

JSPR Articles
This Week
▼
1

2
▲
JSPR Articles
Average Week

Get Jasper Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:JSPR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Jasper Therapeutics (JSPR) News Today

JSPR Media Mentions By Week

JSPR Media Sentiment

JSPR News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info